{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-25-000071","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.378966+00:00","generated_at":"2026-05-17T21:26:53.586669+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intensity Therapeutics raises $6.6M via ATM stock sales; cash runway extended to H2 2026","bullets":["Gross proceeds of $6.6M ($6.3M net) from sale of 19,868,658 shares at avg $0.3323/share in July 2025.","Shares outstanding post-ATM: 46,035,081 as of July 31, 2025.","Average price per share >10% higher than June 2025 public offering, reducing dilution cost.","Proceeds extend cash runway into second half of 2026 to advance clinical trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-25-000071","json":"https://secwatch.observer/filing/0001567264-25-000071.json","markdown":"https://secwatch.observer/filing/0001567264-25-000071.md","text":"https://secwatch.observer/filing/0001567264-25-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/0001567264-25-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/intensity-20250804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:26:53.586669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}